FDA Approved: XPHOZAH 10 MG — Supplemental Application (Ardelyx, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for XPHOZAH 10 mg (tenapanor) from Ardelyx, Inc., expanding the drug’s approved use or dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia in Chronic Kidney Disease On Dialysis

Drugs mentioned

• XPHOZAH 10 MG (TENAPANOR)

Snippet

SUPPL AP for XPHOZAH 10 MG (TENAPANOR)